[Previous Months][Date Index][Thread Index][Join - Register][Login]   Help@Insulin-Pumpers.org
  [Message Prev][Message Next][Thread Prev][Thread Next]   for subscribe/unsubscribe assistance
 
 

[IP] medtronic cutting job s FYI



Medtronic to cut 1,100 jobs from global work force
MORE FROM BUSINESSWEEK
	* India Losing Status as Offshore King?
	* At Kia, Demoted for His Own Good
	* Five Mistakes to Avoid During a Downturn
	* Shrinking Job Market a Worry for India
	* A Visa Squeeze for Foreign MBAs
More from BusinessWeek
	* Yahoo's Yodel Turns Into a Whimper
	* The Lesson of Societe Generale
	* FBI Widens Its Subprime Net
	* Altria's Split: Where There's Smoke
	* Under Armour's Footwear Foray
Story Tools
	* order a reprint
	* digg this
	* save to del.icio.us
MINNEAPOLIS
Medical device maker Medtronic Inc. said Tuesday it is planning to cut its
work force by about 1,100 jobs, or about 3 percent, during the current fiscal
year as part of a global restructuring.
Spokeswoman Marybeth Thorsgaard said the cuts will come from Medtronic
businesses that are no longer growing at previous rates, but she did not
specify which ones. She also said the company would add jobs in fast-growing
businesses, including neuromodulation devices.
She said some manufacturing and research and development operations will be
consolidated.
For example, the company intends to consolidate endovascular manufacturing in
its Galway, Ireland, facilities while moving jobs from Santa Rosa, Calif. It
also intends to move research and development functions for its
beneath-the-skin diagnostics and monitoring products from the Netherlands to
Minneapolis.
Thorsgaard said Fridley-based Medtronic employs about 39,500 people worldwide,
with about 60 percent in the United States and 40 percent overseas.
Medtronic's shares closed Tuesday down 3 cents at $49.01.
In February, the company reported that its third-quarter earnings fell 89
percent from the year before due to charges from lawsuit settlements and
acquisition costs.
Medtronic said it earned $77 million, or 7 cents per share, in the quarter
that ended Jan. 25, compared with $710 million, or 61 cents per share, a year
earlier.
Excluding the charges, Medtronic would have earned $713 million, or 63 cents
per share.
President and Chief Executive Officer Bill Hawkins said it was a difficult
quarter for the company's core cardiac rhythm disease management business due
to a recall of its Sprint Fidelis wires in late 2007.
However, he predicted a stronger fourth quarter with the launch of its
Endeavor drug-coated stents in the United States and the addition of other
products.
Thorsgaard said Tuesday that the global reorganization was independent of both
events and said the company "is growing at a healthy 9 percent to 11 percent"
rate.
Medtronic is scheduled to report its fourth-quarter and year-end results on
May 20.
 Christene


      _______________________________________________________________________
_____________
Be a better friend, newshound, and
know-it-all with Yahoo! Mobile.  Try it now.
http://mobile.yahoo.com/;_ylt=Ahu06i62sR8HDtDypao8Wcj9tAcJ
.
----------------------------------------------------------
for HELP or to subscribe/unsubscribe/change list versions,
contact: HELP@insulin-pumpers.org